16 results
8-K
EX-99.1
DAWN
Day One Biopharmaceuticals, Inc.
25 Jul 24
Ipsen and Day One enter into exclusive ex-U.S. licensing agreement to commercialize tovorafenib for the most common childhood brain tumor
6:04am
options. We believe Ipsen’s footprint in Europe and major regions outside of the U.S., in addition to their track record of bringing innovative medicines … ; financial instability of international economies and sovereign risk; dependence on the effectiveness of Ipsen’s patents and other protections for innovative
8-K
EX-14.1
DAWN
Day One Biopharmaceuticals, Inc.
8 Dec 23
Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
4:05pm
to attract the most creative, innovative and committed people from across the globe.
Fair Employment Practices
We are committed to providing equal
8-K
EX-99.1
DAWN
Day One Biopharmaceuticals, Inc.
7 Aug 23
Day One Reports Second Quarter 2023 Financial Results and Corporate Progress
4:30pm
with other innovative therapies.”
Program Highlights
On June 4, 2023, Day One announced new clinical data from the registrational Phase 2 FIREFLY-1
8-K
EX-99.1
DAWN
Day One Biopharmaceuticals, Inc.
1 May 23
Day One Reports First Quarter 2023 Financial Results and Corporate Progress
9:01am
. During his long tenure at Roche and Genentech, Dr. Rousseau built a team solely dedicated to developing innovative treatments for children
PRE 14A
rq1g40p0rsuf49m
18 Apr 23
Preliminary proxy
4:05pm
8-K
EX-99.1
wsavmwa n07m
12 Sep 22
Day One Appoints Garry Nicholson as Chairman of the Board of Directors
8:40am
DEF 14A
lcx tkdyxd
28 Apr 22
Definitive proxy
4:44pm
10-K
0r3yhs8hjqwplts64s
7 Mar 22
Annual report
7:36am
8-K
EX-99.1
pskbi1fnx qb8ku
7 Mar 22
Day One Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Progress
7:30am
424B4
8j7cv2fe7n9uu3c1
27 May 21
Prospectus supplement with pricing info
4:18pm
S-1/A
bbu7 ltyd4g1enz3
24 May 21
IPO registration (amended)
6:16am
S-1
b1sjugqe
4 May 21
IPO registration
4:12pm
DRS
nlkx d297
19 Mar 21
Draft registration statement
12:00am
- Prev
- 1
- Next